Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2007
Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failureXander Ht Wehrens
The Journal of Clinical Investigation|November 13, 2018
STAT3: a link between CaMKII-βIV-spectrin and maladaptive remodeling?Mohit Hulsurkar, Ann P Quick, Xander Ht Wehrens
The Journal of Clinical Investigation|October 1, 2021
Cellular regeneration as a potential strategy to treat cardiac conduction disordersSatadru K Lahiri, Mohit M Hulsurkar, Xander Ht Wehrens
JCI Insight|March 19, 2026
Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse modelRong-Chi Hu, Mohammadreza Tabary, Xander Ht Wehrens, et al.
JCI Insight|January 26, 2021
Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophyAshish N Rao, Hannah M Campbell, Xiangnan Guan, et al.
Life Science Alliance|March 4, 2024
Altered myocardial lipid regulation in junctophilin-2-associated familial cardiomyopathiesSatadru K Lahiri, Feng Jin, Yue Zhou, et al.
Arrhythmia & Electrophysiology Review|March 20, 2026
Atrial Cardiomyopathy and Atrial Fibrillation in Different Heart Failure SubstratesBharat K Kantharia, Lingling Wu, Mohit M Hulsurkar, et al.
JCI Insight|June 21, 2019
Junctophilin-2 expression rescues atrial dysfunction through polyadic junctional membrane complex biogenesisSören Brandenburg, Jan Pawlowitz, Benjamin Eikenbusch, et al.
The Journal of Clinical Investigation|January 8, 2020
Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathyEric Himelman, Mauricio A Lillo, Julie Nouet, et al.
The Journal of Clinical Investigation|March 6, 2025
Macrophage-mediated IL-6 signaling drives ryanodine receptor-2 calcium leak in postoperative atrial fibrillationJoshua A Keefe, Yuriana Aguilar-Sanchez, J Alberto Navarro-Garcia, et al.
Pageof 2